| 11.75 Data as of May 17 |  -0.24 / -2.00%Today’s Change | 6.25 Today|||52-Week Range 12.85 | +57.09% Year-to-Date |
| Previous close | 11.99 |
| Today’s open | 12.02 |
| Day’s range | 11.68 - 12.10 |
| Volume | 862,897 |
| Average volume (3 months) | 520,591 |
| Market cap | $784.1M |
| Dividend yield | -- |
| Earnings growth (last year) | -88.06% |
| Earnings growth (this year) | -1,098.44% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -31.36% |
| P/E ratio | NM |
| Price/Sales | 9.24 |
| Price/Book | 5.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACHNAchillion Pharmaceut... | +0.21 | +2.78% |
| AUXLAuxilium Pharmaceuti... | -0.04 | -0.27% |
| OPTROptimer Pharmaceutic... | -0.14 | -0.93% |
| CBPOChina Biologic Produ... | +0.34 | +1.30% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $53.1M |
| Annual profit (last year) | $5.0M |
| Net profit margin | 9.46% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Kevin C. Gorman, PhD, MBA |
Vice President-Information Technology & Operations Bill Wilson |
Corporate headquarters San Diego, California |
.
